Kovack Advisors, Inc. Northwest Biotherapeutics Inc Put Options Transaction History
Kovack Advisors, Inc.
- $988 Million
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding NWBO
# of Institutions
12Shares Held
732KCall Options Held
0Put Options Held
0-
Moloney Securities Asset Management, LLC502KShares$120,3740.02% of portfolio
-
Vsm Wealth Advisory, LLC Hunt Valley, MD65.6KShares$15,7370.01% of portfolio
-
Opus Capital Group, LLC60.2KShares$14,4360.0% of portfolio
-
Williams Jones Wealth Management, Llc. New York, NY27KShares$6,4800.0% of portfolio
-
Ethos Financial Group, LLC King Of Prussia, PA25.4KShares$6,0840.0% of portfolio
About NORTHWEST BIOTHERAPEUTICS INC
- Ticker NWBO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 1,037,230,016
- Market Cap $249M
- Description
- Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, wh...